Ast Pesaro-Urbino presenta i numeri del territorio
Risultati per: Standard di cura nel diabete 2024
Questo è quello che abbiamo trovato per te
Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up
Annals of Internal Medicine, Ahead of Print.
Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines
Annals of Internal Medicine, Ahead of Print.
Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up
Annals of Internal Medicine, Ahead of Print.
Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines
Annals of Internal Medicine, Ahead of Print.
Audio Highlights December 28, 2024–January 10, 2025
Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.
What to Expect From a Low-Nicotine Product Standard for Cigarettes
This Viewpoint discusses the public health benefits that could be gained if the US Food and Drug Administration (FDA) were to mandate very low-nicotine-content cigarettes (VLNCs).
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2024
A contemporary report describing the burden and expenditures of gastrointestinal (GI) diseases can be helpful for policy makers, administrators, and researchers. Using the most recent data, we estimated the burden and costs associated with GI diseases in the United States.
A Microbiome-directed therapy for malnutrition that performs better than standard nutritional interventions.
Lowell A. Goldsmith, MD, 1938-2024
Lowell A. Goldsmith, MD, MPH, was a leader in dermatology.
Magnini, 'prendetevi cura del vostro cuore, ve ne sarà grato'
Il campione di nuoto testimonial del progetto Rete Cardiologica
Abstract WP90: Cost of Stroke Treatment: A Comparative Analysis of Mobile Stroke and Standard Treatment
Stroke, Volume 56, Issue Suppl_1, Page AWP90-AWP90, February 1, 2025. Introduction:Over the past decade, Mobile Stroke Treatment Units (MSTU) have enhanced the quality of stroke care in the United States by bringing the hospital to the patient. While MSTUs improve stroke patient outcomes compared to standard hospital care, there are still limited units operating. The implementation of a MSTU requires considerable initial and long-term investment limiting their widespread programmatic formation. We evaluated a MSTU program in Florida between August 2023 and April 2024 for comparative patient associated out of pocket costs with MSTU and standard stroke care.Methods:A discrete time Markov Chain Monte Carlo (MCMC) model was used to estimate incremental cost-savings associated with MSTU treatment compared to standard hospital care. The Markov model captured treatment costs for the care of patients at two functional levels as defined by the modified Rankin Scale (mRS). The potential cost-savings was determined by comparing the estimated costs incurred by the MSTU cohort to a counterfactual scenario of standard care of Emergency Medical Services (EMS) transport to the Emergency Department (ED). Since the model focused on the cost of patient care, costs included only billed ED, inpatient, and outpatient hospital care and services provided in the baseline year and then estimated cost of care over the next four years. All values represent 2024 dollars ($) and a 3% discount rate was applied to years two through four.Results:The MSTU treated 59 acute stroke patients with an average age of 71.86 (SD=13.78). Overall, 76% (N=45) were diagnosed with ischemic stroke, 9% with intracerebral hemorrhage (ICH), and 15% with transient ischemic attack (TIA). At discharge, 54% were independent and 46% dependent. In Year 1 (baseline), out of pocket cost differential between MSTU patients and the standard care was estimated to be $5,306 and $6,485 for the independent and dependent patients respectively. Projected future cost differentials in Years 2 to 4 were $4,571, $3,845, and $2,817 for the independent functioning cohort and $5,586, $4,700, and $4,188 for the dependent functioning cohort.Conclusion:These results suggest that the out of pocket cost for MSTU patients was significantly lower than standard care both at baseline and over the first four years post-stroke, making MSTU acute stroke management a better economic system of care for time metrics, long term patient outcomes, and cost effectiveness.
Abstract TP388: Integrating standard-of-care clinical stroke workup within in silico embolic stroke models for etiology disambiguation
Stroke, Volume 56, Issue Suppl_1, Page ATP388-ATP388, February 1, 2025. Introduction:Embolic Stroke of Undetermined Source (ESUS) accounts for a critical proportion of all ischemic strokes. Disambiguating embolism etiology is important to improve treatment efficacy and reduce recurrent events. Patient-specific in silico models can shed valuable insights on embolus source-destination mapping. This requires reliable and accurate pre/post-stroke hemodynamic models, which benefit from integrating multiple modes of patient information from imaging and clinical records. This is a major state-of-the-art challenge. Here, we present a workflow for multi-modal data integration from standard-of-care workup towards recreating a data-rich digital twin of stroke patients.Methods:Our workflow integrates non-contrast and contrast-enhanced head-neck CT and cardiac CT, trans-thoracic echo, and perfusion imaging, along with clinical variables such as HR, systolic/diastolic volumes, and stroke locations (with NIHSS scores). Quantitative data from these sources are then integrated into a hemodynamic model by processing features such as arterial structure, inlet flow, tuned resistance boundary conditions, cardiac timing, and stroke location. Resulting hemodynamic data was used to further simulate embolus movement towards stroke site. Statistical sampling simulations using this model were conducted to evaluate the likelihood that an occlusion location corresponded to cardiogenic, aortogenic, or other arterial sources.Results:We present our complete in silico workflow, and demonstrate the outcomes using a small cohort of 5 patients acquired from a clinical database (anonymized, IRB exempt). We demonstrate that the workflow yields high-resolution space-time varying patient hemodynamic patterns. Additionally, the embolus source-destination likelihood mapping provides detailed quantitative insights on the embolism etiology in these stroke patients. These findings indicate that our workflow and resulting digital twins can be a valuable tool in addressing the current clinical challenges in discerning embolism etiology in ESUS cases.Conclusions:We introduce a pipeline of transforming raw patient-specific information from multi-modal imaging and clinical parameters into a cohesive, data-rich in silico model for embolic stroke comprising the full heart-to-brain pathway. This offers a flexible digital twin approach for elucidating stroke etiologies in patient-specific scenarios.
Abstract HUP6: Area Deprivation Index Associated with Time to Presentation in Acute Ischemic Stroke and Eligibility for Standard Window versus Late Presenter Thrombolysis
Stroke, Volume 56, Issue Suppl_1, Page AHUP6-AHUP6, February 1, 2025. Introduction:Prior studies have demonstrated social determinants of health (SDoH) are associated with reduced rates of intravenous thrombolysis (IVT) for acute ischemic stroke (AIS), including in disadvantaged populations. Mechanisms of disparity may include financial/resource limitations and systemic bias. Neighborhood measures of socioeconomic status are predictors of interest in stroke research, as they may influence emergency response, transportation, and health seeking behaviors. We sought to identify SDoH factors influencing time to presentation for AIS.Methods:This is a retrospective cohort study of 432 patients ages ≥18 presenting to Tufts comprehensive stroke center with AIS and last known well (LKW)
Abstract TP299: Area Deprivation Index Associated with Time to Presentation in Acute Ischemic Stroke and Eligibility for Standard Window versus Late Presenter Thrombolysis
Stroke, Volume 56, Issue Suppl_1, Page ATP299-ATP299, February 1, 2025. Introduction:Prior studies have demonstrated social determinants of health (SDH) are associated with reduced rates of intravenous thrombolysis (IVT) for acute ischemic stroke (AIS), including in disadvantaged populations. Mechanisms of disparity may include financial/resource limitations and systemic bias. Neighborhood measures of socioeconomic status are predictors of interest in stroke research, as they may influence emergency response, transportation, and health seeking behaviors. We sought to identify SDH factors influencing time to presentation for AIS.Methods:This is a retrospective cohort study of 432 patients ages ≥18 presenting to Tufts comprehensive stroke center with AIS and last known well (LKW)
Evolving Epidemiology of Mpox in Africa in 2024
New England Journal of Medicine, Ahead of Print.